Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study
Abstract Background Despite improvements in the management of renal cell carcinomas (RCC) with the advent of immunotherapy, only a few patients respond to these treatments. Predictors of response to nivolumab are currently being investigated but are still lacking. Aim of the study To evaluate eosino...
Shranjeno v:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2021-10-01
|
| Serija: | Cancer Medicine |
| Teme: | |
| Online dostop: | https://doi.org/10.1002/cam4.4208 |
| Oznake: |
Brez oznak, prvi označite!
|